Arterial Hypertension Clinical Trial
— ATACAOfficial title:
Analysis of Antihypertensive Treatment Efficacy
Analysis of antihypertensive treatment efficacy.
Status | Terminated |
Enrollment | 2000 |
Est. completion date | February 2009 |
Est. primary completion date | February 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - arterial hypertension - intake of Atacand before study enrollment Exclusion Criteria: - hypersensitivity to candesartan or any other ingredient of Atacand - liver function impairment and/or cholestasis - severe renal insufficiency (serum creatinine > 265 µmol/L) - Pregnant and lactating women |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Russian Federation | Research Site | Arhangelsk | |
Russian Federation | Research Site | Bryansk | |
Russian Federation | Research Site | Domodedovo | |
Russian Federation | Research Site | Dzerzhinsk | |
Russian Federation | Research Site | Ekaterinburg | |
Russian Federation | Research Site | Essentuki | |
Russian Federation | Research Site | Georgievsk | |
Russian Federation | Research Site | Irkutsk | |
Russian Federation | Research Site | Kazan | |
Russian Federation | Research Site | Samara | |
Russian Federation | Research Site | Severodvinsk | |
Russian Federation | Research Site | Vidnoe | |
Russian Federation | Research Site | Volgograd |
Lead Sponsor | Collaborator |
---|---|
AstraZeneca |
Russian Federation,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Analysis of antihypertensive treatment efficacy. | measurement BP: 3 visits for 3 month | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05684055 -
"Community-based, eHealth Supported Management of Cardiovascular Risk Factors by Lay Village Health Workers (ComBaCaL aHT TwiC 1 & ComBaCaL aHT TwiC 2)
|
N/A | |
Active, not recruiting |
NCT05436730 -
"Escape" Phenomenon of the Antihypertensive Therapy Efficacy
|
||
Not yet recruiting |
NCT03294070 -
Fimasartan Plus Amlodipine on Hemodynamic Parameters and Arterial Stiffness in Patients With Hypertension
|
Phase 4 | |
Recruiting |
NCT01959997 -
Comparison of Redo PVI With vs. Without Renal Denervation for Recurrent AF After Initial PVI
|
Phase 2 | |
Completed |
NCT00983632 -
Selective Vagus Nerve Stimulation in Human
|
N/A | |
Recruiting |
NCT06098300 -
Effects of Change in Blood Pressure on Retinal Capillary Rarefaction in Patients With Arterial Hypertension
|
||
Completed |
NCT04564118 -
A Retrospective Analysis of the Adherence to Clinical Practice Guidelines Using the "MedicBK" Digital Platform in Patients With Hypertension and Atrial Fibrillation
|
||
Terminated |
NCT04677322 -
TO ASSESS THE EFFECTIVENESS OF THE INTERVENTION OF THE LOW-SODIUM DIET IN PATIENTS WITH HTA
|
||
Completed |
NCT04278001 -
Clinical Usefullness of the Cuffless SOMNOtouch NIBP Device for 24-hour Ambulatory Blood Pressure Measurement
|
N/A | |
Withdrawn |
NCT03047538 -
Fixed Combination for Lipid and Blood Pressure Control
|
Phase 4 | |
Completed |
NCT03046264 -
Invasive Validation of Non-invasive Central Blood Pressure Measurements Using Oscillometric Pulse Wave Analysis
|
N/A | |
Completed |
NCT02620995 -
Effects of Sildenafil on Penile Vascular Function in Hypertensive Men With Erectile Dysfunction
|
Phase 4 | |
Completed |
NCT02041832 -
Detection of Subclinical Atrial Fibrillation in High Risk Patients Using Implantable Loop Recorder
|
N/A | |
Completed |
NCT01459120 -
Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural Lesotho
|
N/A | |
Completed |
NCT01546181 -
Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases
|
||
Recruiting |
NCT01132001 -
Ambulatory Versus Home Blood Pressure Measurement
|
N/A | |
Completed |
NCT01454583 -
Registry for Ambulant Therapy With RAS-Inhibitors in Hypertension-patients in Germany
|
N/A | |
Recruiting |
NCT03917758 -
Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors
|
N/A | |
Completed |
NCT03722524 -
The Use of TrIple Fixed-dose Combination in the Treatment of Arterial Hypertension
|
||
Completed |
NCT03539627 -
Azilsartan Medoxomil in Hypertensive pAtients With Stable Ischemic Heart Disease and DiabEtes MEllitus.
|